Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders
Obesity Science & Practice · 2024-08 · 10 (4)
DOI: 10.1002/osp4.784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Science & Practice, online erschienen am 13.08.2024. Verfasst von Sherri L LaVela und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterans Affairs Center of Innovation for Complex Chronic Healthcare (CINCCH) Edward Hines Jr. VA Hospital Hines Illinois USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Veterans Affairs, Health Services Research and Development.
Abstract (Originalsprache)
Background
Anti‐obesity medications (AOMs) may provide a viable option for obesity management. However, little is known about the use of AOMs in persons with SCI/D.
Objective
Describe health care providers' (HCPs) views about barriers to AOM use in persons living with SCI/D.
Methods
Descriptive qualitative design using in‐depth interviews Descriptive statistics were used to calculate demographic and employment characteristics. Interviews were audio‐recorded and transcribed verbatim. Transcripts were coded and analyzed using Braun and Clarke's (2006) six thematic analysis phases.
Results
HCPs (n = 12) were from 11 different nationwide facilities. Most HCPs were male (75%), a large majority were white (67%), and most were 26–49 years of age. Participants were dietitians (75%), physicians (17%), and psychologists (8%). HCPs ranged from 1.5 to 15 years of providing SCI/D care. HCPs described four main thematic barriers to AOM use in persons with SCI/D: (1) AOM side effects that are especially concerning in persons with SCI/D; (2) AOMs contribute to poor eating habits; (3) availability, accessibility, and administration; and (4) lack of evidence, clinical agreement, and knowledge about AOM use in the SCI/D population.
Conclusions
There are several potential barriers to AOM use in the SCI/D population. Barriers include AOM side effects which may cause or exacerbate conditions that are already concerns in persons with SCI/D, such as bowel and skin problems, and muscle loss. SCI/D HCPs reported a lack of evidence about AOM use in persons with SCI/D, but interest in obtaining more knowledge.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterans Affairs Center of Innovation for Complex Chronic Healthcare (CINCCH) Edward Hines Jr. VA Hospital Hines Illinois USA.
- Department of Physical Medicine and Rehabilitation Feinberg School of Medicine Northwestern University Chicago Illinois USA.
- Department of Physical Medicine and Rehabilitation University of Miami Miller School of Medicine Miami Florida USA.
- Miami Project to Cure Paralysis University of Miami Miller School of Medicine Miami Florida USA.
- Department of Physical Medicine and Rehabilitation SUNY Upstate Medical University Syracuse New York USA.
- Center for Innovation to Implementation VA Palo Alto Health Care System Palo Alto California USA.
ORCID-Profile: Sherri L LaVela, Kelsey Berryman, Ibuola Kale, Gary J Farkas, Geoffrey V Henderson, Vanessa Rosales, Dan Eisenberg, Lorena Reyes
Förderung
- U.S. Department of Veterans Affairs
- Health Services Research and Development
Zitieren
APA
LaVela, S. L., Berryman, K., Kale, I., Farkas, G. J., Henderson, G. V., Rosales, V., Eisenberg, D., & Reyes, L. (2024). Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders. Obesity Science & Practice, 10(4). https://doi.org/10.1002/osp4.784
Vancouver
LaVela SL, Berryman K, Kale I, Farkas GJ, Henderson GV, Rosales V, et al. Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders. Obesity Science & Practice. 2024;10(4). doi:10.1002/osp4.784
BibTeX
@article{LaVela2024,
author = {LaVela, Sherri L and Berryman, Kelsey and Kale, Ibuola and Farkas, Gary J and Henderson, Geoffrey V and Rosales, Vanessa and Eisenberg, Dan and Reyes, Lorena},
title = {Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders},
journal = {Obesity Science & Practice},
year = {2024},
volume = {10},
number = {4},
doi = {10.1002/osp4.784}
}
EUVIMED